Bright Minds Biosciences announced a non-brokered private placement with expected gross proceeds of $35 million. The company's stock is currently trading with a session volume of about 10.6 million.
Colossal Biosciences is making significant strides in its ambitious project to bring back the thylacine, also known as the Tasmanian tiger, a species that has been extinct since 1936. The company ...
FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its ...
Some results have been hidden because they may be inaccessible to you